Geographic Atrophy

Geographic atrophy lesion location may be a critical factor in vision-related quality of life, according to a presentation at Angiogenesis, Exudation, and Degeneration 2025.

KOLOA, Hawaii — In this Healio Video Perspective from Retina 2025, Baruch D. Kuppermann, MD, PhD, and Rishi P. Singh, MD, current and past presidents of Retina World Congress, preview this year’s meeting.

KOLOA, Hawaii — In this Healio Video Perspective from Retina 2025, Roger A. Goldberg, MD, MBA, discusses the role of multimodal imaging in geographic atrophy in the era of complement inhibitors.

The K8 implant, a first-in-class dual inflammasome inhibitor, demonstrated positive efficacy and safety at 3 months in five patients with bilateral geographic atrophy, according to a press release from Inflammasome Therapeutics.

CHICAGO — In this video, Clement K. Chan, MD, FACS, discusses highlights from the AAO meeting, including presentations on pegcetacoplan and avacincaptad pegol for the treatment of geographic atrophy.

CHICAGO — In this video from the AAO meeting, Joan W. Miller, MD, chair of ophthalmology at Mass Eye and Ear, discusses the role of AREDS vitamins in slowing the progression of geographic atrophy.

City Therapeutics and Bausch + Lomb have entered into a strategic collaboration focused on the development of an RNA interference-based treatment for geographic atrophy, according to a press release.

CHICAGO — In this video, Clement K. Chan, MD, FACS, recaps a lecture from the Macula Society symposium at the AAO meeting.

Aviceda Therapeutics secured $207.5 million in Series C financing to advance the AVD-104 program in geographic atrophy, according to a press release.

Healio spoke with Nathan M. Radcliffe, MD, about disparities that exist in glaucoma care.